EBioMedicine
Journal Title
- EBioMedicine
ISSN
- E 2352-3964
Publisher
- Elsevier BV
Listed on(Coverage)
| JCR | 2017-2023 |
|---|---|
| SJR | 2015-2020;2022-2023 |
| CiteScore | 2014-2023 |
| SCIE | 2017-2024 |
| SCOPUS | 2017-2024 |
| MEDLINE | 2016-2024 |
| DOAJ | 2017-2024 |
| EMBASE | 2016-2024 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | basic science, clinical science, translational, genetics, drug targeting, biomedicine |
| Review Process | Anonymous peer review |
| Journal info. pages | |
| Licences | CC BY, CC BY-NC-ND |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Medicine (General) |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- NETHERLANDS
Aime & Scopes
- EBioMedicine is the premium gold open access venue for translational biomedical research. The journal is dedicated to publishing original research that elucidates, or aims to modify, disease pathways and mechanisms-with the goal of advancing our knowledge in any biomedical discipline with relevance to human health. We publish papers investigating the basic determinants of human health and disease, the discovery and characterization of new therapeutic targets and treatments, and the identification of biomarkers and diagnostic tools which may help researchers and clinicians better understand and monitor disease. EBioMedicine covers the whole spectrum of biomedical research, from preclinical studies with clear human relevance, through to proof-of-concept studies and clinical trials. The journal will also publish relevant reviews, commentaries and opinion pieces. We aspire to catalyse dialogue and collaboration between basic scientists, clinical researchers and healthcare professionals, enhance the accessibility and applicability of basic research findings for health professionals, and promote a better understanding of clinical challenges for biomedical researchers.